Back
Perspective Therapeutics Stock Price Chart
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Buy
65
CATX
Perspective Therapeutics
Last Price:
13.71
Seasonality Move:
0.46%
7 Day Trial
ALL ACCESS PASS
$
7
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.69 | Buy |
| 20-day SMA: | 11.75 | Buy |
| 50-day SMA: | 12.66 | Buy |
| 200-day SMA: | 9.05 | Buy |
| 8-day EMA: | 12.76 | Buy |
| 20-day EMA: | 12.23 | Buy |
| 50-day EMA: | 12.48 | Buy |
| 200-day EMA: | 10.25 | Buy |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 60.71 | Buy |
| Chaikin Money Flow: | 924007 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.19 - 12.61) | Buy |
| Bollinger Bands (100): | (11.03 - 15.83) | Buy |
Perspective Therapeutics Technical Analysis
| Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 13.62 while CATX 8-day simple moving average is 12.69, which is a Buy signal.
- The stock price of CATX is 13.62 while Perspective Therapeutics 20-day SMA is 11.75, which makes it a Buy.
- Perspective Therapeutics 50-day simple moving average is 12.66 while CATX share price is 13.62, making it a Buy technically.
- CATX stock price is 13.62 and Perspective Therapeutics 200-day simple moving average is 9.05, creating a Buy signal.
CATX Technical Analysis vs Fundamental Analysis
Buy
65
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a Buy
The current Perspective Therapeutics [CATX] share price is $13.62. The Score for CATX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
918.19M
Price in USD:
13.62
Share Volume:
1.05M
Perspective Therapeutics 52-Week Range
52-Week High:
19.05
52-Week Low:
2.05
Buy
65
Perspective Therapeutics (CATX)
is a Buy
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?
The Perspective Therapeutics stock price is 13.62 USD today. -
Will CATX stock go up or go down?
Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Perspective Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is not overvalued.
Is Perspective Therapeutics Stock a Buy?
- Perspective Therapeutics share price is 13.62 while CATX 8-day exponential moving average is 12.76, which is a Buy signal.
- The stock price of CATX is 13.62 while Perspective Therapeutics 20-day EMA is 12.23, which makes it a Buy.
- Perspective Therapeutics 50-day exponential moving average is 12.48 while CATX share price is 13.62, making it a Buy technically.
- CATX stock price is 13.62 and Perspective Therapeutics 200-day simple moving average is 10.25, creating a Buy signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
- CATX Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Perspective Therapeutics is a Buy
- Perspective Therapeutics Relative Strength Index (RSI) is 60.71, which suggest Perspective Therapeutics is overbought
- The Bollinger Bands (25) for Perspective Therapeutics is (10.19 - 12.61), which suggest Perspective Therapeutics is a Buy
- The Bollinger Bands (100) for Perspective Therapeutics is (11.03 - 15.83), which suggest Perspective Therapeutics is a Buy
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.